We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Industry Pipeline.
- Abstract
The article covers issues related to ophthalmology as of October 2014. Dexamethasone intravitreal implant Ozurdex was approved by the U.S. Food and Drug Administration (FDA) for the treatment of diabetic macular edema. Eylea aflibercept injection was approved by the European Commission for the treatment of visual impairment due to diabetic macular edema. Clinical studies to evaluate the safety and efficacy of lampalizumab for geographic atrophy were initiated by healthcare company Roche.
- Subjects
EUROPE; RESEARCH evaluation; MEDICAL societies; ORPHAN drugs; PRESS; OPERATIVE surgery; UNITED States. Food &; Drug Administration; DRUG approval
- Publication
Ocular Surgery News, 2014, Vol 32, Issue 20, p34
- ISSN
8750-3085
- Publication type
Article